Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

616
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
616
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

99
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
99
Human Genetics01:28

Human Genetics

1.3K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.3K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

147
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
147
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

147
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
147
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

146
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical pharmacogenetics: A feasibility study of pharmacy students using a clinical decision support system during their didactic training.

Innovations in pharmacy·2026
Same author

Home Blood Pressure Telemonitoring Technology for Patients With Asymptomatic Elevated Blood Pressure Discharged From the Emergency Department: Pilot Study.

JMIR formative research·2023
Same author

Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore.

Family practice·2022
Same journal

A CanMEDS-Based Approach to Physician Evaluation and Performance Assessment.

Healthcare management forum·2026
Same journal

Designing Rupture Discs in Healthcare Systems: A Practical Framework for Risk-Focused Leadership.

Healthcare management forum·2026
Same journal

The Cost of Homecare Personal Support Worker Turnover.

Healthcare management forum·2026
Same journal

A Multi-Level Approach to Health Promotion for Long-Haul Truck Drivers.

Healthcare management forum·2026
Same journal

Walking Together: Advancing Culturally Grounded Diabetes Care in Indigenous Communities.

Healthcare management forum·2026
Same journal

Timely Availability and Accessibility of Health Data: Meeting the Challenge of Pan-Canadian Health Charter Principle 6.

Healthcare management forum·2026
See all related articles

Related Experiment Video

Updated: Dec 28, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.5K

Pharmacogenetics in primary care.

Martin Dawes1

  • 1Department of Family Practice, The University of British Columbia, Vancouver, British Columbia, Canada.

Healthcare Management Forum
|February 15, 2020
PubMed
Summary
This summary is machine-generated.

Pharmacogenetic testing is expanding for anxiety and depression treatment due to unpredictable medication responses. Over a third of patients have variants affecting drug metabolism, highlighting the need for clinical decision support tools.

More Related Videos

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.9K
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.3K

Related Experiment Videos

Last Updated: Dec 28, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.5K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.9K
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.3K

Area of Science:

  • Pharmacogenomics
  • Clinical Pharmacology
  • Genetics

Background:

  • Pharmacogenetic information is increasingly adopted, with insurance coverage expanding for conditions like anxiety and depression.
  • Implementation is driven by challenges in medication predictability, adverse drug events, and treatment efficacy.
  • A significant portion of patients (over one-third) possess pharmacogenetic variants impacting drug metabolism.

Purpose of the Study:

  • To highlight the growing importance and challenges of integrating pharmacogenetic information into clinical practice.
  • To underscore the impact of pharmacogenetic variants on medication response beyond psychiatric conditions.
  • To introduce medication decision support software as a potential solution for managing pharmacogenetic data.

Main Methods:

  • Review of current trends in pharmacogenetic testing implementation.
  • Analysis of the prevalence and implications of pharmacogenetic variants.
  • Discussion of challenges in clinical application and potential technological solutions.

Main Results:

  • Pharmacogenetic testing is becoming mainstream, particularly for anxiety and depression.
  • Pharmacogenetic variants are common and affect the metabolism of various medications.
  • Integrating evolving pharmacogenetic data into clinical practice is complex.

Conclusions:

  • Pharmacogenetic information is crucial for optimizing medication selection and improving patient outcomes.
  • Medication decision support software can aid clinicians in navigating complex pharmacogenetic data.
  • Continued research and updated guidelines are essential for widespread, effective pharmacogenetic implementation.